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Megan Miller: Comparison of PCR Methodologies for the Detection and  
Quantification of SARS-CoV-2 in North Carolina Community Wastewaters 
(Under the direction of Jill Stewart) 
 
Wastewater surveillance has been proven as a viable method for monitoring pathogen 
presence and prevalence during infectious disease outbreaks in communities. This approach can 
be utilized during the current COVID-19 pandemic to monitor the existence and concentration of 
the SARS-CoV-2 virus in community wastewaters. Methods for the surveillance of non-
enveloped viruses are more present in the literature, but standardization of wastewater 
surveillance methods for enveloped viruses, such as SARS-CoV-2, is needed. This study 
compares the performance of two PCR-based methodologies, RT-qPCR and RT-ddPCR, for the 
detection and quantification of SARS-CoV-2 in influent samples from two NC wastewater 
treatment plants (WWTPs). Sample collection, processing, RNA extraction, and RT-ddPCR 
analyses were completed for samples collected over a 24-week period. RT-qPCR assays were 
performed on identical samples as RT-ddPCR for comparison purposes, and the effects of matrix 
inhibition on both methods were evaluated for a subset of samples. This study found a significant 
difference between the detection sensitivity of RT-qPCR and RT-ddPCR. RT-ddPCR detected a 
statistically greater occurrence of SARS-CoV-2 than RT-qPCR for both WWTPs. A decrease in 
sensitivity differences between the methods was found when values quantified below the RT-
qPCR LOD were considered in the dataset. This study suggests that RT-qPCR demonstrates 
useful analytical sensitivity for the detection of SARS-CoV-2, particularly when values below 
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the LOD/LOQ are considered to a limited extent. RT-ddPCR was found to be the preferred 
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Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the highly infectious 
causative agent of the Coronavirus Disease 2019 (COVID-19) pandemic. Since the first 
diagnosed case in Wuhan, China, the effects of the pandemic have been keenly felt in over 219 
countries. As of April 7, 2021, the pandemic has resulted in approximately 131 million cases 
worldwide, over 2.8 million deaths, economic disruption, political unrest, and declining mental 
health outcomes, among others (Coronavirus Update (Live), n.d.). The US exceeded 500,000 
deaths from COVID-19 in February 2021.  
Understanding disease trends in order to predict prevalence of SARS-CoV-2 in 
communities is crucial for mitigating the spread of the virus and effectively distributing 
resources throughout affected populations. SARS-CoV-2 is a single-stranded, positive sense 
RNA Betacoronavirus that is primarily transmitted via respiratory droplets and aerosol pathways 
(Lu et al., 2020). It is estimated that as many as 40-45% of cases present as asymptomatic, 
meaning that an individual can be positive for the presence of the virus, while not exhibiting 
typical symptoms such as cough, fever, or shortness of breath (Oran & Topol, 2020). Due to the 
high asymptomatic case rate, testing for the virus must include both symptomatic and 
asymptomatic individuals in order to accurately capture infection rates throughout communities. 
This requires extensive testing networks and high volumes of testing resources. From April 1, 
2020 to February 23, 2021, over 328 million tests were given in the US, averaging at 14.46 tests 
per positive case over the period (Hasell et al., 2020). Although the cost per individual test varies 
widely across states and healthcare providers, assuming a lower than average cost of $100/test 
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means that each positive case costs over $1446 in testing costs alone (“COVID-19 Test Prices 
and Payment Policy,” n.d.). These costs put enormous economic strain on communities and can 
result in inadequate testing due to a lack of resources. Therefore, it is important to identify 
alternative ways of quantifying COVID-19 prevalence throughout communities. 
Although SARS-CoV-2 is primarily transmitted via aerosol and respiratory droplet, 
infected individuals also shed virus in their stool. It is estimated that approximately 12% of cases 
reported gastrointestinal symptoms, such as diarrhea. Even if gastrointestinal symptoms were not 
reported, 40-50% of cases shed feces positive for SARS-CoV-2 RNA at concentrations as high 
as 108 virus-copies/g (Parasa et al., 2020; Singer & Wray, 2020; Wölfel et al., 2020; Wong et al., 
2020). SARS-CoV-2 has also been detected in fecal samples of patients that received several 
negative results from RT-qPCR tests of nasopharyngeal swabs. Wastewater surveillance could 
more accurately quantify the total number of individuals positive for SARS-CoV-2 in a 
community by including a higher number of asymptomatic cases (Chen et al., 2020). Community 
wastewaters represent a viable alternative pathway for identifying the presence of SARS-CoV-2 
and COVID-19 in communities.  
One of the main challenges for widespread implementation of wastewater surveillance 
for SARS-CoV-2 is the lack of optimized and standardized methods (Kitajima et al., 2020). 
Well-developed methods exist for the detection and quantification of non-enveloped viruses, but 
the implementation of standardized methods for enveloped viruses, such as SARS-CoV-2, 
requires further research and collaboration. Wastewater matrices for wastewater treatment plants 
(WWTPs) also vary widely depending upon source water, population demographics, flow rates, 
and service area characteristics. As such, methods for wastewater surveillance of SARS-CoV-2 
may need to shift depending on the local wastewater matrix of the WWTP.  
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The objective of this research was to compare reverse transcriptase quantitative 
polymerase chain reaction (RT-qPCR) and reverse transcriptase droplet digital polymerase chain 
reaction (RT-ddPCR) methodologies for the quantification and detection of SARS-CoV-2 in 
North Carolina community wastewaters. Sample collection and processing, as well as all RT-
ddPCR analyses used in this study, were the result of a collaborative effort of the Stewart Lab 
and completed as a part of the NC Policy Collaboratory Wastewater Pathogen Tracking Research 
Network (LaMontagne et al., 2021). All RT-qPCR and inhibition data was generated as the result 
of individual work. Analyses were performed on batched 24-hour composite wastewater samples 
collected from two different WWTPs in the Piedmont region of North Carolina. The network 
was comprised of 16 labs across North Carolina collecting wastewater samples in communities 
throughout the state. The goal of the network was a joint effort to quantify the SARS-CoV-2 
virus in wastewater samples and connect the concentrations back to COVID-19 cases of the users 
in the studied sewersheds. While the network focused on the development of SARS-CoV-2 
surveillance methods as a whole, this research focused on the following objectives: 
 
1. Comparing the analytical sensitivity of RT-qPCR and RT-ddPCR for the detection of 
SARS-CoV-2. 
2. Comparing the effects of the NC wastewater matrix on inhibition experienced by RT-
qPCR and RT-ddPCR. 
3. Evaluating whether RT-qPCR offers sufficient detection reliability in comparison with 







2. REVIEW OF THE LITERATURE 
Since the emergence of COVID-19 throughout Wuhan, Hubei Province, China, extensive 
research efforts across the globe have been dedicated to preventing the spread of COVID-19. At 
the core of this research is the development of detection and surveillance measures for SARS-
CoV-2 (Alygizakis et al., 2021). Detection-based measures focus on the creation of robust 
testing/surveillance networks throughout communities, which are crucial for effective 
containment of the virus. Due to high asymptomatic case rates leading to inconsistent reporting 
of symptoms, the logistical/resource requirements, and turnaround testing time associated with 
necessary testing rates, additional surveillance methods are needed as an alternative to sampling 
at the individual level (Daughton, 2020; Mao et al., 2020; Polo et al., 2020).  
Alternative Testing and Surveillance Methods 
Standard tests involve a nasopharyngeal swab of the patient and quantification of the 
SARS-CoV-2 virus using RT-qPCR. Several solutions have been proposed as alternatives. 
Batch-testing, which involves the pooling of samples from groups of individuals, would require 
individual tests only if the pool returned a positive result. This would allow testing centers to 
increase screening capacity by 2-20 times that of individual-focused testing centers (Pilcher et 
al., 2020). Self-administered paper strip tests would allow for the wide-spread distribution of 
cost-effective testing to individuals in their homes. However, concerns have emerged related to 
the proper administration of the tests and potential harmful outcomes from false negatives 
(Pettengill & McAdam, 2020). Both of these alternative methods target virus present in the 
nasopharyngeal tract, but it is important to note that up to 50% of infected individuals shed virus 
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in their stool, regardless of the presence of detectable symptoms (Parasa et al., 2020). A 
combination of pool sampling and the presence of SARS-CoV-2 in feces can be applied in a 
broader context to the surveillance of SARS-CoV-2 in community wastewaters. 
Wastewater-based Epidemiology 
Wastewater-based epidemiology (WBE) is an emerging field that has proven successful 
in the detection of infectious disease biomarkers in wastewaters, which can be used as early 
warning signs of outbreaks in communities (Mao et al., 2020). Within the polio eradication 
initiative, the WHO recommends the wastewater surveillance of poliomyelitis as a supplemental 
approach since it has been successful in detecting and assessing the extent of polio infections in 
various communities (Vaccine Assessment and Monitoring - WHO, 2003). Poliomyelitis, a 
human enterovirus, persists in wastewaters and can retain its infectivity in the wastewater matrix 
for up to two months, making it an ideal candidate for wastewater surveillance measures (Ndiaye 
et al., 2014). This has been one of the most widespread successes of WBE and helped contribute 
to the eradication of wild polio from the African continent – official as of August 2020 (World 
Health Organization, 2020).  WBE has also been successful in detecting various human 
enteroviruses, Hepatitis A, and variations of the human herpes virus (McCall et al., 2020; 
Pellegrinelli et al., 2013) 
Existing Wastewater Surveillance Methods 
Human enteroviruses (e.g. adenovirus/norovirus) are the most common targets of a WBE 
approach, as they are non-enveloped and cause symptoms that result in excessive shedding of 
virus through fecal pathways, such as diarrhea. Enveloped respiratory viruses, such as influenza, 
are less common targets of WBE. These viruses are mainly spread through droplets or aerosols, 
and are generally thought to break down more easily in wastewaters, resulting in a loss of 
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infectivity due to damage sustained by the lipid envelope (Polo et al., 2020). Due to the 
perception of enveloped viruses’ limited persistence in water systems, the literature lacks 
methods for detecting enveloped viruses in wastewaters. However, certain enveloped viruses, 
such as SARS-CoV and MERS, have been found to persist in sewer systems longer than 
previously thought. Persistence seems to outlast the average hydraulic residence times of sewer 
networks, resulting in their introduction to WWTPs. Recent studies have found that SARS-CoV-
2 similarly persists in wastewaters, making it viable for WBE approaches (Polo et al., 2020; 
Wigginton et al., 2015). 
Development of SARS-CoV-2 Surveillance Methods 
Recognition of the viability of wastewater surveillance for SARS-CoV-2 has led to the 
study and optimization of surveillance methods. Initial studies in Australia detected positive 
samples from a single WWTP using a combination of RNA extraction via electronegative 
membranes and detection/quantification via RT-qPCR. RT-qPCR had already proven successful 
in the detection of SARS-CoV-2 in human secretion samples for the purpose of identifying 
positive clinical patients, and therefore has been applied to the detection of the virus in many 
recent wastewater surveillance projects (Ahmed, Bivins, et al., 2020; Medema et al., 2020; 
Sherchan et al., 2020; Shirato et al., 2020; Westhaus et al., 2021). RT-qPCR is also a highly 
accessible and familiar method across state, academic, and WWTP laboratories.  
Recently published studies found potential issues relating to RT-qPCR’s analytical 
sensitivity for wastewater-based detection of SARS-CoV-2. Potential negatives for the method 
include low COVID-19 prevalence in the community and inhibitors in the wastewater matrix 
(Alygizakis et al., 2021; Randazzo et al., 2020). However, several monitoring programs have 
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achieved sensitivities with RT-qPCR down to detecting 2.6 gene-copies/mL, indicating that 
sensitivity may depend upon the specific wastewater matrix (Medema et al., 2020). 
Other surveillance studies utilized an alternative PCR based method (reverse transcriptase 
droplet digital PCR [RT-ddPCR]), which relies on the absolute quantification of the target, rather 
than a target concentration based upon the external calibration of a standard curve, as in RT-
qPCR (Gonzalez et al., 2020). RT-ddPCR achieves absolute quantification via a water-oil 
emulsion droplet system that partitions nucleic acid samples into nanoliter-sized droplets. Each 
of these droplets acts as an individual well in a standard PCR plate, allowing for a single sample 
concentration to be based upon a Poisson distribution of tens of thousands of reactions in a single 
run (Droplet DigitalTM PCR (DdPCRTM) Technology | LSR | Bio-Rad, n.d.). Some studies found 
RT-ddPCR to have increased sensitivity for both patient sample evaluation and wastewater 
surveillance purposes, making it ideal for samples with a low viral load. Others reported 
improved performance of RT-qPCR over RT-ddPCR for solid waste samples (Alygizakis et al., 
2021; D’Aoust et al., 2021; Liu et al., 2020). 
A common issue when determining optimal methods for wastewater surveillance of a 
pathogen, is the inhibition of the assay’s polymerase chain reaction from the components of the 
surrounding wastewater matrix. These compounds can be naturally occurring in the water source 
or anthropogenically introduced. Inhibition is most concerning in large volume environmental 
water samples, with wastewater containing some of the highest concentrations of potential 
inhibitors. For large volumes of environmental samples, studies have reported a high chance of 
false negatives (up to 71%) when inhibition was not considered (Gibson et al., 2012). RT-ddPCR 
helps to reduce inhibition, according to some hypotheses, as the partitioning of the sample into 
thousands of droplets effectively dilutes inhibitor concentrations per reaction. Other studies have 
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postulated the opposite – claiming that the ratio of targeted nucleic acid to inhibitors actually 
increases when partitioned into the RT-ddPCR droplets, resulting in increased inhibition 
(D’Aoust et al., 2021; Dingle et al., 2013). Determining the extent of the effects of inhibitors in 
the studied wastewater matrix is crucial to making an informed decision regarding the 
appropriate quantification and detection method for wastewater surveillance of SARS-CoV-2.  
One must also consider that RT-qPCR is significantly more accessible than RT-ddPCR, 
due to the high cost of the required equipment and reagents for the latter (Insight Pharma Reports 
2013). Determining the balance between analytical sensitivity and economic costs of different 
quantification methods of the SARS-CoV-2 virus in wastewater is crucial, as states and 
communities are currently developing their own surveillance methodologies. As noted above, 
wastewater matrices differ widely across geographies, and recognition of this nuance is also 
















3. MATERIALS AND METHODS 
 
3.1 Sample Collection 
In collaboration with two local WWTPs, 24-hour batched composite influent samples were 
collected weekly from WWTPs of differing profiles in Pittsboro, NC and Chapel Hill, NC over a 
24-week sampling period (Figure 3-1). Table 3-1 describes the makeup and capacities of the two 
studied WWTPs. 
Table 3-1. Attributes of studied WWTPs. Courtesy of Dr. David Holcomb. 
 Make-up Operating Capacity Sewershed 
Area 
Residents 
OWASA Residential, University, 
Industrial, Hospital, Retail  
14.5 MGD 76.2 km2 ~83,000 




Samples of ≥250mL were collected by WWTP staff each week. Samples were placed on ice and 













3.2 Sample Processing 
Primary influent samples were heat pasteurized at 75°C for 30 minutes. After heat 
pasteurization, a Bovine coronavirus modified live vaccine (BCoV) (PBS animal health 16445) 
was added in a 1:1000 ratio to sample volume for 17 sampling dates (7/10-10/27), and a 1:10000 
ratio to sample volume for 7 sampling dates (11/3-12/15), as a processing control (Gonzalez et 
al. 2020). The added concentration was changed mid-way through the period of sample 
processing, due to oversaturation of BCoV in initial RT-ddPCR results. After the addition of 
BCoV, the sample was acidified to a pH of 3.5 with 10 M HCl, and MgCl2 x 6H2O was added in 
a 1:1000 ratio to sample volume (Ahmed, Bivins, et al., 2020). A 50mL sample of phosphate 








































































Figure 3-1. Maps of studied sewersheds – OWASA (a) in Orange County, NC and the Pittsboro 
WWTP (b) in Chatham County, NC. (OWASA, 2019) (WK Dickson, 2018) 
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including acidification and addition of MgCl2 and BCoV. Virus was concentrated via filtration in 
20mL volumes through mixed ester cellulose 40mm membrane filters fit on single use funnels 
(EZ-Fit™ Filtration Units). Filters and funnels were changed for each replicate. After filtration, 
the filter-funnel apparatus was rinsed with PBS, and the filter transferred to cryovials containing 
600uL of lysis buffer using sterile forceps. Due to availability, NucliSENS Lysis Buffer 
(Biomerieux 380134) was used for 5 sampling dates (7/10-8/6) and Qiagen RLT Plus lysis buffer 
was used for the remaining 19 dates (8/11-12/15). Filters were stored in 600uL of lysis buffer at  
-80°C. While composite primary solid samples were processed, they were not used in this 
experiment. See Figure 3-2 for the sample processing workflow diagram. 
3.3 RNA Extraction 
Frozen samples were extracted weekly within 10 days of sample collection and 
processing, using the QIAGEN RNeasy Plus mini kit. Manufacturer instructions were followed 
with an additional bead-beating step prior to extraction. Prior to extraction, 5uL of Armored 
Hepatitis G virus (Asuragen #42024) was added to each thawed sample tube as an extraction 
control. Contents of stored filters (i.e. filter plus 600ul of storage lysis buffer) were sterilely 
transferred to garnett bead tubes from the QIAGEN DNeasy PowerSoil kit and beaten for 120 
seconds at 5000rpm in a BioSpec Products Mini-BeadBeater 3110 BX. Tubes were then 
centrifuged at 8000xg for 30 seconds. Supernatant from the beaten tubes was then passed 
through gDNA columns in 600uL volumes and centrifuged at 8000xg for 30 seconds. Flow 
through was then transferred to a clean collection tube and 70% ethanol added in a 1:1 ratio to 
sample volume. The sample was then passed through RNA binding columns in 700uL volumes 
and centrifuged at 8000xg for 30 seconds. 700uL of RW1 buffer was then passed through the 
RNA binding column, followed by 500uL of buffer RPE working solution. Between each buffer 
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rinse, columns were centrifuged at 8000xg for 30 seconds. 500uL of buffer RPE working 
solution was added a second time and the column centrifuged at 8000xg for 2 minutes. The RNA 
spin column was then placed in a new, capless collection tube, 75uL of RNase-free water added, 
and centrifuged at 8000xg for 1 minute. The resulting eluate was passed through the column a 
second time and spun as before. Eluate from the second pass was then aliquoted into 3 volumes 

























































































































3.4.1 Assay Specifications 
Quantification of SARS-CoV-2 in RNA extracted from collected influent wastewater 
samples was conducted using RT-qPCR. Following CDC recommendations, N1 and N2 primer-
probe sets were purchased via the 2019 nCoV Research Use Only Kit (IDT 10006713) for 
quantification (CDC, 2020). See Table 3-2 for the specific primer-probe sequences used for both 
the N1 and N2 targets. Quantitative Synthetic SARS-CoV-2 RNA: ORF, E, N (ATCC VR-
3276SD™) was purchased and used for standard curves and as a positive control. The iTaq 
universal probes One-Step kit for RT-qPCR (Bio-rad #1725141) was used per manufacturer 
instruction. Amplifications were performed in 20uL reaction mixtures containing 10uL of Super 
Mix, 0.5 uL of reverse transcriptase enzyme (RT), 1.5uL of primer/probe mixture (503nM of 
forward primer, 503nM of reverse primer, 128nM of probe), 3uL of nuclease free water, and 5uL 
of RNA template. Reactions were run under the following conditions: 50°C for 10 minutes for 
reverse transcription and 95°C for 1 minute for denaturation. Then, 40 cycles were run of 95°C 
for 10 seconds and 60°C for 30 seconds on a BioRad CFX96 Touch thermal cycler (Bio-Rad 
Laboratories). All reactions were run in duplicate, with each RT-qPCR plate containing a five-









Table 3-2. Nucleic Acid sequences used for Taqman® probe-based PCR methods by target. 
 
3.4.2 Determining Limit of Detection and Limit of Quantification for RT-qPCR 
To determine the limit of detection (LOD) and limit of quantification (LOQ) for RT-qPCR, 3 
RT-qPCR runs containing 8 standard concentrations in replicates of 4 were run for each target. 
This provided 12 replicates for each of the 8 standard concentrations across all plates. The 8 
concentrations ranged from (6645 copies/uL - Std. 1) to (0.30 copies/uL - Std.8). A detection rate 
of 75% was needed across the 12 replicates to include the standard concentration in the LOD 












  TCT GGT TAC TGC CAG TTG AAT CTG 
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Coronavirus bCoV probe FAM-CCTTCATATCTATACACATCAAGTTGTT-BHQ-1 
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calculations. The LOD was determined by averaging the Ct values for the lowest qualifying 
concentration for each target, and then calculating the related concentration of SARS-CoV-2 per 
reaction. The LOQ was determined by subtracting 2 standard deviations of the lowest standard's 
Ct values from the LOD Ct value, and again calculating the related concentration per reaction. 
Values below the LOD and LOQ were kept in the data set but were indicated as such in all tables 
and figures. 
3.4.3 Concentration Calculations 
SARS-CoV-2 concentrations present in influent wastewater samples were calculated 
from measured RT-qPCR Ct values. A standard curve equation was derived for each target on 
each plate from the Ct values of the known standards. A calibrator Ct was calculated by 
averaging the Ct values for the first standard concentration. The average target amplification 
factor was calculated via Equation 1. Concentrations of SARS-CoV-2 per reaction were adjusted 
for reaction efficiency by multiplying the ratio of the calibrator to unknown samples (derived in 
Equation 2 below) by the concentration of the calibrator (e.g. Std. 1 concentration). This value 
was then multiplied by an elution correction factor and divided by the volume filtered to yield 
concentrations in gene-copies/mL or gene-copies/µL. 
Equation 1: 𝐴𝑣𝑒𝑟𝑎𝑔𝑒	𝑇𝑎𝑟𝑔𝑒𝑡	𝐴𝐹 = 10(
/0
12345) 
Equation 2:          789:;	<8=:>?89;?
@ABA;CA
= 	 (𝐶9	(<8=:>?89;?) − 𝐶9	 @ABA;CA )F8?GH9	IJ 
Figure 0-3. Equations used for calculation of RT-qPCR sample concentrations. 
3.4.4 Classification of Sample Dates 
To determine an overall classification for each sampling date from its two replicates the 
following procedure was used: if both replicates were non-detect, detected at levels below the 
LOD (Positive (below the LOD)), detected at levels below the LOQ (Positive), or detected at 
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levels above the LOD/LOQ (averaged concentration in gene-copies/L), then that date was 
designated as such. If one replicate was non-detect and the other was detected at levels below the 
LOD, the date was designated as Positive (below LOD). If one replicate was detected at levels 
above the LOD/LOQ and one detected at levels below the LOD, the date was designated as 
Positive. If one replicate was detected at levels below the LOD and one at levels below the LOQ, 
the date was designated as Positive. If one replicate was detected at levels below the LOQ and 
one was a non-detect, the date was designated as Positive (below LOD). If one replicate was 
detected at levels below the LOQ and one above the LOQ, the average concentration of the two 
was given for the date in gene-copies/L, and if one replicate was a non-detect and the other 
detected at levels above the LOD/LOQ, the averaged concentration of the two was given. All 
non-detects were treated as having concentrations of zero. 
3.5 RT-ddPCR 
SARS-CoV-2 in extracted RNA from collected influent wastewater samples also 
underwent absolute quantification via the Bio-Rad QX200 Droplet Digital PCR System. N1 and 
N2 primer/probe sets were again used per CDC recommendation (Table 3-2. Nucleic Acid 
sequences used for Taqman® probe-based PCR methods by target.). The Bio-Rad One-Step RT-
ddPCR Advanced Kit for Probes (1864021) was used according to manufacturer's instruction 
with modification to increase the total reaction volume from 20uL to 22uL. RT-ddPCR Master 
Mix consisted of 5.5uL of Supermix, 2.2uL RT, 914nM of forward primer, 914nM of reverse 
primer, 232nM of probe, 5.2uL nuclease-free water, and 1.1uL DTT per reaction. Prior to droplet 
generation, reaction mixtures were vortexed and centrifuged for 30 seconds to ensure proper 
mixing. For droplet generation, using an Eppendorf multichannel pipette, 20ul of each reaction 
mixture was loaded into an 8-well cartridge, compressing the plunger to only the first stop to 
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avoid introducing air into the sample. In the same cartridge, 70uL of generation oil was added to 
each well, the cartridge covered with a gasket, and placed into the Bio-rad CFX200 Droplet 
Generator per manufacturer instruction. Once droplet generation was complete, 43uL of droplets 
per reaction were transferred to a skirted 96-well plate, and the plate sealed in a Bio-Rad PX1 
PCR Plate Sealer. The reverse transcription and PCR took place in a BioRad C1000 Touch 
Thermal Cycler under the conditions described in the 1-step RT-ddPCR Advanced Kit for Probes 
product insert (available on the Bio-Rad website). Cycling conditions were as follows: 25°C for 
3 minutes, followed by 50°C for 1 hour and 95°C for 10 minutes. The reaction was then run for 
45 cycles of 95°C for 30 seconds for denaturation and 55°C for 1 minute for 
annealing/extension. After undergoing the PCR, the plate was transferred to the Bio-Rad 
CFX200 droplet reader for SARS-CoV-2 quantification. BioRad QuantaSoft Analysis Pro 
version 1.0.596 software was used for droplet count analysis, manual setting of the threshold, 
and target concentration calculation. Samples were considered non-detect or were excluded if 
total droplet count was less than 10000 droplets and/or if the total number of positive droplets 
was < 3. Resulting concentrations were adjusted for elution volume and membrane filter volume 
and reported as gene-copies/uL and gene-copies/L.  
3.6 Determining Inhibition 
An experiment was conducted on a subset of samples to determine the level of inhibition 
present in both the RT-qPCR and RT-ddPCR assays. A subset of samples was used due to low 
availability of sample volumes from common extractions. The SPUD assay was chosen as the 
inhibition control. See Table 3-2 for primer, probe, and template sequences (Nolan et al., 2006; 
Van Heetvelde et al., 2017). The SPUD template was first prepared by heating it at 55°C for 20 
minutes and the concentration initially quantified via RT-ddPCR. For RT-qPCR, the reaction 
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consisted of 8uL Super Mix, 0.4uL RT, 1.2 uL primer/probe mixture (503nM of forward primer, 
503nM of reverse primer, 128nM of probe), 2.4uL nuclease free water, 5uL sample matrix, and 
3uL spike of SPUD template at a known concentration, totaling to a 20uL reaction volume. A 
five-point standard curve was created in triplicate using known concentrations of SPUD-T spiked 
into nuclease-free water. Positive controls were made by using nuclease-free water as template 
and also spiked with 3uL of SPUD-T. Three wells served as non-template controls. Cycling 
conditions were as follows: 95°C for 30 seconds, followed by 40 cycles of 95°C for 10 seconds 
and 60°C for 30 seconds (Nolan et. al 2013). The resulting difference in the Ct values of samples 
versus positive controls were evaluated for indication of the presence of significant inhibition in 
the assay. For RT-ddPCR, the reaction consisted of 5.5uL of Supermix, 2.2uL RT, 914nM of 
forward primer, 914nM of reverse primer, 232nM of probe, 2.2uL nuclease-free water, 1.1uL 
DTT, 5uL sample matrix, and 3uL spike of SPUD template. Three wells were spiked with 3uL of 
SPUD-T into nuclease-free water as positive controls, and three wells served as non-template 
controls. Cycling conditions were as follows: 95°C for 5 minutes, followed by 40 cycles of 95°C 
for 5 seconds and 60°C for 20 seconds. This was followed with 98°C for 10 minutes for enzyme 
deactivation and 4°C for 30 minutes (Nolan et. al 2013; Van Heetvelde et al. 2017). The positive 
controls were compared with resulting concentrations from sample matrices and the percent 
difference used as percent inhibition (Rački et al., 2014). A paired t-test was run in R to 
determine if the quantified sample SPUD concentrations were statistically different from the 
positive control. 
3.7 Viral Processing Efficiency 
The known spiked concentration of BCoV during sample processing was used to 
determine method processing efficiency of an enveloped, RNA coronavirus. The spiked BCoV 
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underwent identical processing as the influent sample, including concentration via membrane 
filtration and extraction, making it a valid indicator for processing efficiency.  
3.7.1 RT-qPCR 
Bovine coronavirus was quantified in the extracted RNA from collected influent wastewater 
samples via RT-qPCR in the same manner as SARS-CoV-2, with the exception of a BCoV 
specific primer/probe mixture (503nM forward primer, 503nM reverse primer, 128nM probe per 
20uL reaction). See specific sequences in Table 3-2. A positive control of BCoV was prepared 
by heating 10uL aliquots of the stock solution at 100°C for 5 minutes. Positive controls were run 
in the form of a 5-point standard curve in replicates of 4 with 3 non-template controls for each 
plate. Cycling conditions were identical to SARS-CoV-2 targets. 
3.7.2 RT-ddPCR 
BCoV was run in duplex with Hepatitis G for absolute quantification via RT-ddPCR. The 
assay was run in the same manner as SARS-CoV-2, with the exception of the additional 
primer/probe set. The extra 3uL of primer/probe per reaction was accounted for by decreasing 
the volume of nuclease-free H2O per reaction from 5.2uL to 2.2uL. BCoV primer/probe 
concentrations in the 22uL reaction were the same as that of N1/N2 for RT-ddPCR. Heat 
activation of the positive control was the same as for RT-qPCR. A dilution series of positive 
controls were initially run and the dilution with optimum band separation for the duplex was 
chosen as the positive control concentration. All subsequent BCoV positive controls were run at 
a 1:1000 dilution of the stock solution. Cycling conditions were identical to SARS-CoV-2. 





3.7.3 Efficiency Calculations 
Percent of BCoV lost during sample processing was calculated for both RT-qPCR and 
RT-ddPCR. For RT-qPCR, the concentration of BCoV gene-copies yielded from a processed 
20mL filter was calculated using the same procedure as SARS-CoV-2. All non-detects were 
coded with a value of zero. The concentration of BCoV stock solution was quantified via RT-
ddPCR, and was found to be approximately 33641 gene-copies/uL. The expected number of 
copies yielded from a 20mL filter was derived from the known spike volume of BCoV stock at 
the start of sample processing. Gene-copies detected per 20mL filter were averaged across all 
samples, and then divided by the expected number of gene-copies/20mL filter. The resulting 
percentage was used as the processing efficiency for the entire method, including RT-qPCR. The 
same process was used to determine processing efficiency of the method including RT-ddPCR, 
except values were calculated in copies/uL rather than copies/20mL filter. 
3.8 Quality Control for All Assays 
All RT-qPCR plates were run with a minimum of three non-template controls and all RT-ddPCR 
plates with a minimum of two non-template controls. All non-template controls in this study 
were negative. Each RT-qPCR plate contained a five-point standard curve in triplicate. All 
standard curves had R2 values greater than 0.98, and all RT-qPCR reactions across all targets had 
87% efficiency or greater. The LOD set for RT-qPCR corresponded to a Ct value that fell within 
the standard curve values of all RT-qPCR plates. All target standards were quantified via RT-
ddPCR for use in RT-qPCR. 
3.9 Statistical Analyses 
The results of the RT-qPCR and RT-ddPCR assays were evaluated using the Spearman-Rank 
Correlation test to determine whether there were differences between the N1/N2 targets within 
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each method. Comparison of the two methods was done using the McNemar’s chi-square test to 
determine if there were differences in detection sensitivity. This was followed by the Spearman-
Rank Correlation test to determine if correlation existed between the SARS-CoV-2 
concentrations quantified by each method to evaluate quantification agreement between the two 


























The method utilizing RT-ddPCR resulted in a higher rate of positive samples (70.2%) across 
all replicates of targets for both WWTPs as compared to RT-qPCR (31.7%). Considering 
samples detected at concentrations below RT-qPCR’s LOD increases the detection rate to 56.1%. 
However, this still underperforms the detection rate of RT-ddPCR. As aliquoted samples from 
identical extractions were used, this indicates a superior level of sensitivity for the RT-ddPCR 
method. 
4.2 Viral Recovery Efficiency 
The efficiency of processing methods and subsequent viral loss during sample processing was 
quantified with bovine coronavirus. Recovery efficiencies for the method including RT-qPCR 
were highly variable. Average recovery was 2.65% with recoveries ranging from 0.0% to 58.9%. 
The method including RT-ddPCR also had highly variable recoveries, with an average recovery 
of 8.16%. Recoveries for RT-ddPCR ranged from 0.0% to 66.9%. Due to the variability in 
recovery values for both methods, it is difficult to determine whether the difference in recovery 
values is due to attributes of the methods themselves or the inconsistency of the processing 
control. 
4.3 RT-qPCR 
4.3.1 Limit of Detection / Limit of Quantification 
For RT-qPCR, the average limit of detection (LOD) for N1 was set at 3.3 gene-
copies/reaction and the limit of quantification (LOQ) at 8.9 gene-copies/reaction. For N2, the 
 
	 24 
LOD was set at 3.7 gene-copies/reaction and the LOQ set at 9.5 gene-copies/reaction. See Table 
A-1 for the data used to calculate the LOD/LOQ. All extraction blanks and non-template controls 
resulted in non-detects. 
4.3.3 OWASA 
SARS-CoV-2 concentrations were quantified in influent wastewater samples from the 
OWASA WWTP for 24 sampling dates in duplicate, resulting in a total of 48 data points for each 
target. The ratio of non-detect samples to all measured samples across all OWASA sampling 
dates for N1 was 35.4% and 45.8% for N2. Replicate concentrations were classified based on 
LOD/LOQ levels. See Table 4-1 for count data for each category. Classifying all detects found 
below the LOD as non-detects results in a non-detect ratio for N1 of 52.1% (a 16.7% increase) 
and 68.8% (a 23% increase) for N2 across all 48 replicates. 
Table 4-1. Summary of count data of the OWASA WWTP replicates for N1/N2 targets. 
Target Classification Total Num. Replicates Count 
Percentage 
of Samples 





11 22.9% 10 
Below LOQ 12 25.0% 10 
Below LOD 8 16.7% 5 




6 12.5% 3 
Below LOQ 9 18.8% 6 
Below LOD 11 22.9% 8 
Non-detect 22 45.8% 13 
 
Using the procedure outlined in section 3.1.2, each sampling date was classified based on the 
relation of the quantified concentration to the LOD/LOQ. Table 4-2 contains the results for each 




Table 4-2. RT-qPCR concentrations (gene-copies/L) of SARS-CoV-2 in influent wastewater samples for 
targets N1/N2 from the OWASA WWTP over a 24-week sampling period. Each concentration represents 
a classification based upon two replicates. Starred samples indicate that only one replicate was quantified 
due to low available sample volume. 
Date Site Target Concentration (gene-copies/L) Target 
Concentration (gene-
copies/L) 
7/10/20 OWASA N1 2499 N2 3858 
7/14/20 OWASA N1 28948* N2 Positive* 
7/21/20 OWASA N1 41445 N2 33202 
7/28/20 OWASA N1 44965 N2 13197 
8/6/20 OWASA N1 7852 N2 Positive 
8/11/20 OWASA N1 Positive N2 Non-detect 
8/18/20 OWASA N1 Non-detect N2 Non-detect 
8/25/20 OWASA N1 Non-detect N2 Non-detect 
9/1/20 OWASA N1 Non-detect N2 Positive (below LOD) 
9/8/20 OWASA N1 Non-detect N2 Non-detect 
9/15/20 OWASA N1 Non-detect N2 Positive (below LOD) 
9/22/20 OWASA N1 Positive (below LOD) N2 Non-detect 
9/29/20 OWASA N1 Positive (below LOD) N2 Non-detect 
10/6/20 OWASA N1 Positive N2 Non-detect 
10/13/20 OWASA N1 Positive (below LOD) N2 Positive (below LOD) 
10/20/20 OWASA N1 6560 N2 Positive 
10/27/20 OWASA N1 Positive (below LOD) N2 Positive 
11/3/20 OWASA N1 5221 N2 Positive (below LOD) 
11/10/20 OWASA N1 Positive N2 Positive (below LOD) 
11/17/20 OWASA N1 5928 N2 Positive (below LOD) 
11/24/20 OWASA N1 Positive N2 Positive (below LOD) 
12/1/20 OWASA N1 Non-detect N2 Non-detect 
12/8/20 OWASA N1 20830 N2 Positive 
12/15/20 OWASA N1 18015 N2 Non-detect 
 
A Spearman’s Rank-order correlation test was used to determine if correlation existed 
between the N1 and N2 targets for the OWASA WWTP (Table 4-3). Sample date-specific data 
was used for the comparison, with concentrations representing an average of the two replicates 
for that date (N=24). Two scenarios were considered: 1) All values were used, regardless of 
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classification. Non-detects were assigned a value of zero. 2) All positive values were used, and 
all values classified as Positive (below LOD) were considered non-detects and assigned a value 
of zero. 
Table 4-3. Spearman-Rank Correlation Test Results for RT-qPCR Target Comparison for 
OWASA WWTP. 
Scenario N rs p-value 
1. All samples 24 0.74419 3.065E-05** 
2. Positive samples 24 0.64605 0.000649** 
 
Both scenarios contained statistically significant correlation between targets, with a slight 
decrease in correlation and certainty in scenario 2. This is likely due to the higher number of 
Positive (below LOD) samples present for the N2 target. 
4.3.4 Pittsboro 
Viral concentrations were also quantified for samples from the Pittsboro WWTP across 
the 24 sampling dates in duplicate, resulting in a total of 48 data points for each target. See Table 
4-4 for count data for each category of data. The ratio of non-detect samples to all measured 
samples across all duplicate Pittsboro sampling dates for N1 was 52.1% and 47.9% for N2. 
Classifying all detects found below the LOD as non-detects results in a non-detect ratio for N1 of 










Table 4-4. Summary of Replicate count data for Pittsboro WWTP for N1/N2 targets. 
Target Classification Total Num. Replicates Count 
Percentage 
of Samples 





3 6.3% 2 
Below LOQ 9 18.8% 8 
Below LOD 11 22.9% 10 




3 6.4% 2 
Below LOQ 7 14.9% 5 
Below LOD 15 31.9% 11 
Non-detect 22 46.8% 15 
 
Using the procedure outlined in section 3.1.2, each sampling date was classified based on the 
relation of the quantified concentration to the LOD/LOQ. Table 4-5 contains the results for each 















Table 4-5. RT-qPCR concentrations (gene-copies/L) of SARS-CoV-2 in influent wastewater samples for 
targets N1/N2 from the Pittsboro WWTP over a 24-week sampling period. Each concentration represents 
a classification based upon two replicates. Starred samples indicate that only one replicate was quantified 
due to low available sample volume. 
Date Site Target Concentration (gene-copies/L) Target 
Concentration 
(gene-copies/L) 
7/10/20 PITTSBORO N1 Positive N2 Positive 
7/14/20 PITTSBORO N1 Positive (below LOD) N2 Non-detect 
7/21/20 PITTSBORO N1 Non-detect N2 Positive 
7/28/20 PITTSBORO N1 Positive (below LOD) N2 Positive (below LOD) 
8/6/20 PITTSBORO N1 Positive (below LOD) N2 Non-detect 
8/11/20 PITTSBORO N1 477260 N2 261019 
8/18/20 PITTSBORO N1 Positive (below LOD) N2 6895 
8/25/20 PITTSBORO N1 Non-detect N2 Non-detect 
9/1/20 PITTSBORO N1 Positive N2 Positive (below LOD)* 
9/8/20 PITTSBORO N1 Non-detect N2 Positive (below LOD) 
9/15/20 PITTSBORO N1 Non-detect N2 Positive (below LOD) 
9/22/20 PITTSBORO N1 Positive (below LOD) N2 Positive (below LOD) 
9/29/20 PITTSBORO N1 Non-detect N2 Positive (below LOD) 
10/6/20 PITTSBORO N1 Non-detect N2 Non-detect 
10/13/20 PITTSBORO N1 Positive (below LOD) N2 Non-detect 
10/20/20 PITTSBORO N1 Positive (below LOD) N2 Positive (below LOD) 
10/27/20 PITTSBORO N1 Positive (below LOD) N2 Positive (below LOD) 
11/3/20 PITTSBORO N1 Positive (below LOD) N2 Positive (below LOD) 
11/10/20 PITTSBORO N1 Non-detect N2 Non-detect 
11/17/20 PITTSBORO N1 Non-detect N2 Non-detect 
11/24/20 PITTSBORO N1 Positive N2 Positive (below LOD) 
12/1/20 PITTSBORO N1 Positive (below LOD) N2 Positive (below LOD) 
12/8/20 PITTSBORO N1 Positive N2 Positive (below LOD) 
12/15/20 PITTSBORO N1 Positive N2 Positive (below LOD) 
 
A Spearman’s rank-correlation test was done for the Pittsboro WWTP to test for the existence of 
correlation between the two targets. The same two scenarios were tested (Table 4-6).  
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Table 4-6. Spearman-Rank Correlation Test Results for RT-qPCR Target Comparison for the 
Pittsboro WWTP. 
Scenario N rs p-value 
1. All samples 24 0.40539 0.04938** 
2. Positive samples 24 0.13010 0.5446 
 
Scenario 1 contained significant correlation between targets. Scenario 2 did not yield a 
significant result, indicating uncertainty in the presence of correlation between the two targets for 
that scenario. This shift is likely due to the increased number of Positive (below LOD) samples in 
the Pittsboro dataset, resulting in a greater change when these samples were assigned a value of 
zero in Scenario 2.  
4.3.5 WWTP Comparison and temporal trends 
Across the 24 sampling dates, OWASA WWTP samples had higher rates of detection for 
N1 (not considering the LOD cutoff) – 75% positive for OWASA, and 67% positive for 
Pittsboro – whereas Pittsboro had higher rates of detection for the N2 target – 54% for OWASA 
and 71% for Pittsboro for RT-qPCR. Pittsboro samples also had higher rates of low-level SARS-
CoV-2 detection below the LOD than OWASA. Both plants saw an increase in correlation 
between targets when considering values detected at levels below the LOD.  A large spike in 
SARS-CoV-2 concentrations was detected between 7/21 – 8/11 for all targets for both WWTPs, 
followed by several dates of low-level detects/ non-detects between 8/18-9/15 (see Figure 4-1). 
The OWASA WWTP samples indicated a significant spike in SARS-CoV-2 concentrations from 
12/1-12/8, mainly for the N1 target, whereas Pittsboro experienced no marked increase in 




Figure 4-1. Temporal Trends of N1 and N2 target log-concentrations of SARS-CoV-2 over a 24-week 
sampling period for OWASA and Pittsboro WWTPs for RT-qPCR. Each square represents an averaged 
concentration of two replicates. Points are color-coded based on relation to the LOD/LOQ. (a) and (b) = 
N1; (c) and (d) = N2. 
 
The points in Figure 4-1, represent an averaged concentration for the replicates of each 
sampling date for each target. Replicate concentrations were still averaged and graphed if 
detected at levels below the LOD/LOQ in order to represent temporal trends in the data. Points 
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4.3.6 RT-qPCR assay performance 
Plate summary statistics for each RT-qPCR plate can be found in Table A-2. For the N1 
target, reaction efficiencies ranged from 97.157%-101.486% and all R2 values exceeded 0.980. 
For the N2 target, reaction efficiencies ranged from 87.813%-110.057% and all R2 values 
exceeded 0.980.  
4.4 RT-ddPCR 
All RT-ddPCR experiments, analyses and calculations were completed as a result of the 
collaborative effort of the members of the Stewart Lab at the Gillings School of Global Public 
Health (see Acknowledgements). The data is included in this paper for the purposes of a method 
comparison with RT-qPCR.  
4.4.1 Limit of Detection 
Due to absolute quantification via RT-ddPCR, the limit of detection was set at a 
minimum of 3 positive droplets across replicate wells, both containing a minimum of 10,000 
droplets each. This sets the LOD at approximately 1.5 gene-copies/reaction (E. Johnson, personal 
communication, 2020). All extraction blanks resulted in non-detects.    
4.4.2 Classification of Sample Dates 
Due to the absolute quantification of RT-ddPCR, dates were classified as Positive with a 
reported averaged concentration between replicates if  >3 positive droplets were detected across 
replicates, or as Non-detect if  <3 positive droplets were detected across replicates. If one 
replicate classified as Positive and the other as Non-detect, the date was classified as Positive 






Absolute quantification of the presence of SARS-CoV-2 in influent wastewater samples 
from the OWASA WWTP was done via RT-ddPCR. 17% of samples were classified as non-
detects for N1. A total of 39 samples were classified as valid detections out of 47 total replicates. 
The 8 samples classified as non-detects had at least 1 or more positive droplets, but were not 
included in the detect count as they were below the LOD. 23% of samples were classified as 
non-detects for N2. A total of 36 samples had concentrations above the LOD out of the 47 total 
replicates. The results for the Spearman-rank correlation test between targets is seen in Table 
4-7. The test indicated significant, high correlation between the two targets. 
 
Table 4-7. Spearman-Rank Correlation Test Results for RT-ddPCR Target Comparison for all WWTPs. 
Site N rs p-value 
OWASA 24 0.79363 3.70E-06** 
Pittsboro 24 0.81258 1.41E-06** 
 
4.4.4 Pittsboro 
Absolute quantification of the presence of SARS-CoV-2 in influent wastewater samples 
from the Pittsboro WWTP was done via RT-ddPCR. 40.4% of samples were classified as non-
detects for N1. A total of 28 samples were classified as detects out of the 47 replicates. 14 out of 
the 19 samples that were classified as non-detect had at least one positive droplet. For N2, a total 
of 28 samples were classified as detects out of the 47 replicates. 13 out of the 19 samples 
classified as non-detect had at least one positive droplet. 40.4% of samples were classified as 
non-detects for N2. The results for the Spearman-rank correlation test between targets is seen in 





Table 4-8. RT-ddPCR concentrations (gene-copies/L) of SARS-CoV-2 in influent wastewater samples 
for targets N1/N2 from the OWASA WWTP over a 24-week sampling period. Each concentration 
represents a classification based upon two replicates. Starred samples indicate that only one replicate was 
quantified due to low available sample volume (LaMontagne et al, 2021). 
Date Site Target Concentration (gene-copies/L) Target 
Concentration (gene-
copies/L) 
7/10/20 OWASA N1 24416 N2 18100 
7/14/20 OWASA N1 21145 N2 Positive 
7/21/20 OWASA N1 68816 N2 53875 
7/28/20 OWASA N1 Positive N2 30045 
8/6/20 OWASA N1 12093 N2 Non-detect 
8/11/20 OWASA N1 17946 N2 22560 
8/18/20 OWASA N1 140363 N2 56832 
8/25/20 OWASA N1 74731 N2 59376 
9/1/20 OWASA N1 24002 N2 11731 
9/8/20 OWASA N1 11680 N2 Non-detect 
9/15/20 OWASA N1 3845 N2 5456 
9/22/20 OWASA N1 Non-detect N2 Non-detect 
9/29/20 OWASA N1 20275 N2 10008 
10/6/20 OWASA N1 6266 N2 11574 
10/13/20 OWASA N1 4023 N2 Positive 
10/20/20 OWASA N1 12789 N2 10860 
10/27/20 OWASA N1 2465 N2 Positive 
11/3/20 OWASA N1 7425 N2 5551 
11/10/20 OWASA N1 Non-detect N2 Positive 
11/17/20 OWASA N1 15434 N2 19165 
11/24/20 OWASA N1 16624 N2 11230 
12/1/20 OWASA N1 Positive N2 Non-detect 
12/8/20 OWASA N1 4521 N2 7199 









Table 4-9. RT-ddPCR concentrations (gene-copies/L) of SARS-CoV-2 in influent wastewater samples 
for targets N1/N2 from the Pittsboro WWTP over a 24-week sampling period. Each concentration 
represents a classification based upon two replicates. Starred samples indicate that only one replicate was 
quantified due to low available sample volume (LaMontagne et al, 2021). 
Date Site Target Concentration (gene-copies/L) Target 
Concentration (gene-
copies/L) 
7/10/20 PITTSBORO N1 26249 N2 17168 
7/14/20 PITTSBORO N1 4997 N2 Non-detect 
7/21/20 PITTSBORO N1 Positive N2 Non-detect 
7/28/20 PITTSBORO N1 Non-detect N2 8574 
8/6/20 PITTSBORO N1 Non-detect N2 2973 
8/11/20 PITTSBORO N1 207038 N2 279848 
8/18/20 PITTSBORO N1 Positive N2 17148 
8/25/20 PITTSBORO N1 8304 N2 3790 
9/1/20 PITTSBORO N1 Non-detect N2 Non-detect 
9/8/20 PITTSBORO N1 37301 N2 31023 
9/15/20 PITTSBORO N1 4285 N2 3974 
9/22/20 PITTSBORO N1 11170 N2 27943 
9/29/20 PITTSBORO N1 16702 N2 12822 
10/6/20 PITTSBORO N1 Non-detect N2 Non-detect 
10/13/20 PITTSBORO N1 2725 N2 Non-detect 
10/20/20 PITTSBORO N1 Positive N2 Positive 
10/27/20 PITTSBORO N1 Positive N2 6617 
11/3/20 PITTSBORO N1 Positive N2 Non-detect 
11/10/20 PITTSBORO N1 3022 N2 Positive 
11/17/20 PITTSBORO N1 20593 N2 13987 
11/24/20 PITTSBORO N1 Positive N2 Non-detect 
12/1/20 PITTSBORO N1 Non-detect N2 5190 
12/8/20 PITTSBORO N1 7840 N2 11803 






4.4.5 WWTP Comparison and temporal trends 
 Across all 24 sampling dates, OWASA WWTP samples had a higher rate of detection 
across all targets – 83% detection for N1 and 77% for N2 – for RT-ddPCR. Both WWTPs had 
similar levels of correlation between targets. Similar to the RT-qPCR results, RT-ddPCR also 
captured the spike in concentrations from 7/10-8/11. However, RT-ddPCR also detected a 
second, successive spike in SARS-CoV-2 concentrations from 8/11-9/1 that was not detected via 








Figure 4-2. Temporal Trends of N1 and N2 target log-concentrations of SARS-CoV-2 over a 24-
week sampling period for OWASA and Pittsboro WWTPs for RT-ddPCR. Each data point represents an 
averaged concentration of two replicates. Black points indicate non-detects. (a) and (b) = N1; (c) and (d) 
= N2. 
 
4.4.6 RT-ddPCR assay performance 
Due to the absolute quantification of SARS-CoV-2 via RT-ddPCR, the strength of the 
assay is not dependent upon amplification efficiency. Reaction results were considered usable if 







































































4.5 Inhibition Results 
Percent inhibition was determined by the percent difference between sample concentrations of 
SPUD-T and positive controls for RT-ddPCR and RT-qPCR. 
 
Figure 4-3. Comparison of Inhibition present in RT-qPCR and RT-ddPCR for both Pittsboro and 
OWASA WWTPs. Triangles represent extraction blanks, circles PBS blanks, and Xs indicate non-detects. 
The top end of the bars represents the upper replicate value and the lower end of the bar represents the 
lower replicate value. The mean of the two replicates was taken and is represented by the square. 
Comparison of quantified concentrations via the SPUD assay indicates that RT-ddPCR 
experienced higher rates of inhibition from the sample matrix than RT-qPCR ( 
Figure 4-3). Similar or slightly higher concentrations than positive controls were found in spiked 



































































introduced to the samples due to adhesion onto the outside of the pipette tip. However, these 
differences with the positive control were not statistically significant. There was also no 
significant deviance in Ct values for spiked samples from that of the positive control for RT-
qPCR (Table A-3). For RT-ddPCR, significant difference was found between detected sample 
concentrations and positive controls for the Pittsboro WWTP (t = -6.277, p-value = 4.09e-05) but 
not for the OWASA WWTP (t = -2.540, p-value = 0.026).  This indicates the presence of 
significant inhibition in Pittsboro WWTP samples for RT-ddPCR. 
4.6 Methods Comparison  
Almost all detects above the LOD/LOQ for RT-qPCR (96.0%) corresponded with detects from 
RT-ddPCR when comparing the same target and WWTP. 65.7% of RT-qPCR samples detected 
below the LOQ and 63.0% of RT-qPCR samples detected below the LOD corresponded with 
RT-ddPCR detections. Of the RT-ddPCR detections corresponding with RT-qPCR values below 
the LOD, 21.3% were close (< 6 positive droplets) to the RT-ddPCR LOD of 3 positive droplets. 
Correlation between targets for OWASA were similar for both methods (rs ≈ 0.7). However, RT-
ddPCR targets were more correlated for the Pittsboro WWTP (rs ≈ 0.8) than those of RT-qPCR 
(rs ≈ 0.4). This is likely due to the higher rate of uncertainty in the Pittsboro RT-qPCR dataset 
resulting from a high frequency of values around or below the LOD.  
Close to half (43.6%) of positive samples for RT-ddPCR had no level of detection for RT-
qPCR. Only one replicate out of 189 (0.5%) was quantified as a positive sample using RT-qPCR 
and classified a non-detect via RT-ddPCR. Table 4-10 presents replicate counts of agreeing 





Table 4-10. Comparison of replicate counts for sample classifications between RT-qPCR and RT-
ddPCR. Count numbers include both targets and compare classifications of replicate samples. N=188 
for both methods. 
 RT-ddPCR 
RT-qPCR 
 DETECTS NON-DETECTS Total 
DETECTS 24 1 25 
NON-DETECTS 60 22 82 
DETECTS below 
LOD 29 17 46 
DETECTS below 
LOQ 23 12 35 
Total 136 54 188 
 
McNemar’s chi-square test was used to determine if there were significant differences 
between the two methods’ rates of detection. McNemar’s test was chosen to evaluate detection 
rates due to the paired, non-parametric characteristics of the data and the binary nature of 
detection. Contingency tables were created for two scenarios (Table 4-11) based on the counts 
presented in Table 4-10 above. Scenario 1 includes any level of detection for RT-qPCR in the 
category of “Positive”. Only true non-detects are classified as negatives for both methods. 
Scenario 2 only includes detected samples above the LOD in the “Positive” category, which 
would include samples below the LOQ, but above the LOD. Samples detected below the LOD 









Table 4-11. McNemar’s test for comparison between RT-qPCR and RT-ddPCR for the detection of 
SARS-CoV-2 in wastewater. Discordant counts are indicated with stars. 
Scenario 1 RT-ddPCR Positive RT-ddPCR Negative Row Total 
RT-qPCR Positive 76 30* 106 
RT-qPCR Negative 60* 22 82 
Col. Total 136 52 188 
 
Scenario 2 RT-ddPCR Positive RT-ddPCR Negative Row Total 
RT-qPCR Positive 47 13* 60 
RT-qPCR Negative 89* 39 128 
Col. Total 136 52 188 
 
McNemar’s test statistically evaluates the difference in frequency of detection between two 
treatments or methods, in this case: RT-qPCR and RT-ddPCR. The null hypothesis assumes that 
the count of ‘discordant’ samples – those that rank Positive for one method and Negative for the 
other – are equal for both methods, indicating no difference in detection rates. McNemar’s chi-
squared statistic was evaluated using the equation in Figure 4-4. 





The larger the difference in the discordant samples for each method, the greater the chi-squared 
statistic. With an α = 0.05, any McNemar χ2 statistic greater than 3.84 was considered a 
significant difference in detection rate between the two methods. Table 4-12 outlines the results 
for both scenarios. 
Table 4-12. Results of McNemar’s test for various scenarios of sample classification for differing 
methods of SARS-CoV-2 detection in wastewater. Two stars indicates statistical significance. 
Scenario χ2 df p-value 
1. All samples 9.344 1 0.00224** 




Both scenarios indicate a significant difference between the two methods. Scenario 2 yields a 
much greater McNemar’s chi-squared statistic, indicating a much greater difference between the 
detection rates of the two methods for scenario 2 versus scenario 1. This is due to the fact that 
including the samples detected at levels below the RT-qPCR LOD increases the detection rate 
for RT-qPCR, bringing it closer to the detection rate of RT-ddPCR. However, as both scenarios 
result in significant differences between the methods, it strongly suggests that RT-ddPCR is 
better at detecting the presence of SARS-CoV-2 in wastewaters.   
A Spearman’s rank-order correlation test was used to determine whether correlation existed 
between the quantified SARS-CoV-2 concentrations for the two methods. Three scenarios were 
tested – see Table 4-13. In scenario 1, concentration data for all sample dates was considered, 
regardless of classification above or below the LOD. All non-detects were given a value of zero, 
and concentrations for each date represented an average of replicates (N=96). In scenario 2, 
concentrations of all positive sample dates were considered. Sample dates that were classified as 
Positive (below LOD), were treated as non-detects and assigned a value of zero (N=96). In 
scenario 3, only sample dates with concentrations quantified above the LOD/LOQ for both 
methods were considered (N=14). 
Table 4-13. Spearman Rank-Correlation results for method comparison. N = number of samples; rs = 
Spearman correlation coefficient. P-values were calculated using an a=0.05. Two stars indicates 
statistical significance and one star indicates quasi-statistical significance. 
Scenario N rs p-value 
1. All samples 96 0.13554 0.1879 
2. Positive samples 96 0.28520 0.0049** 
3. Above LOD/LOQ samples 14 0.52967 0.0514* 
 
The Spearman correlation coefficient (rs) describes the degree of correlation between the two 
methods, with +1 being completely, positively correlated and -1 being completely, negatively 
correlated. As the specificity of the compared sample set increased, the correlation between the 
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two methods also increased. As scenario 1 did not yield a statistically significant result, we can 
assume very little to no correlation between the two methods when not considering LOD/LOQ 
restrictions for RT-qPCR. Although scenario 3 yielded a p-value slightly greater than 0.05, the 
result can still be considered quasi-significant. Therefore, even with a reduction in sample size, 
only comparing quantifiable values between the two methods (when considering an LOD/LOQ) 
results in an increased correlation between the two methods.  
 
 
Figure 4-5. Heat Map Comparison of Sample Concentration Distribution for RT-qPCR and RT-
ddPCR over the 24-week sampling period. 
 
Figure 4-5 graphically demonstrates the agreement of the two methods via color scale, separated 
by target and WWTP. The majority of RT-qPCR data for each target across both WWTPs is 
made up of values either below the LOD or LOQ; however, 37% of sample dates detected at 
 Detect - above LOD/LOQ 
  Detect - below LOQ 
  Detect - below LOD 
  Non-detect 
 
N2   OWASA   PITTSBORO 
  qPCR ddPCR   qPCR ddPCR 
7/10/20            
7/14/20           
7/21/20           
7/28/20           
8/6/20           
8/11/20           
8/18/20           
8/25/20           
9/1/20           
9/8/20           
9/15/20           
9/22/20           
9/29/20           
10/6/20           
10/13/20           
10/20/20           
10/27/20           
11/3/20           
11/10/20           
11/17/20           
11/24/20           
12/1/20           
12/8/20           
12/15/20             
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7/10/20            
7/14/20           
7/21/20           
7/28/20           
8/6/20           
8/11/20           
8/18/20           
8/25/20           
9/1/20           
9/8/20           
9/15/20           
9/22/20           
9/29/20           
10/6/20           
10/13/20           
10/20/20           
10/27/20           
11/3/20           
11/10/20           
11/17/20           
11/24/20           
12/1/20           
12/8/20           




levels below the LOD and 37% of sample dates detected at levels below the LOQ, detected some 
levels of SARS-CoV-2 where RT-ddPCR was labelled a non-detect.  
 Temporal trends observed in the RT-qPCR data were largely observed via RT-ddPCR as 
well (Figure 4-1 and Figure 4-2). RT-ddPCR data was more likely to detect concentrations of a 
higher magnitude than RT-qPCR. In a comparison of the 14 sampling dates across both WWTPs 
with reported averaged concentrations for both methods, 71.4% reported a greater magnitude for 





















 5. DISCUSSION 
 Throughout a 24-week sampling period from 7/10/20-12/15/20, concentrations of SARS-
CoV-2 were detected in the wastewaters of the OWASA and Pittsboro WWTPs using both RT-
qPCR and RT-ddPCR. Additional studies have also achieved detections in Southeastern US 
wastewaters, as well as in other states and countries across the globe (Ahmed, Angel, et al., 
2020; D’Aoust et al., 2021; Gonzalez et al., 2020). This indicates that wastewater surveillance of 
SARS-CoV-2 is not only possible but a viable method for community-level surveillance.  
 Overall, RT-ddPCR achieved a higher detection rate of SARS-CoV-2 than RT-qPCR 
over the sampling period. Not including samples that were detected below the LOD/LOQ, RT-
qPCR detected reportable concentrations of SARS-CoV-2 in 14.6% of sampling dates across 
both targets and WWTPs, compared with RT-ddPCR’s 81.3%. This difference is even more 
significant when considering that RT-ddPCR experienced greater levels of inhibition than RT-
qPCR, demonstrating its superior sensitivity. This is likely due to several factors. First, RT-
ddPCR relies on absolute quantification of SARS-CoV-2 and therefore does not depend on a 
standard curve or the amplification efficiencies of the reaction. Removing both of these variables 
reduces the chance for error and uncertainty in the sample quantification process. The removal of 
the standard “PCR bias”, combined with the partitioning of the sample into nanoliter-sized 
volumes, allows for the distinction between small differences in target concentration, increasing 
the sensitivity of the method. Capacity for reaction quantity per sample also increases with RT-
ddPCR. A single well contains tens of thousands of droplets, each of which acts as an individual 
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reaction. This further improves the sensitivity and statistical power of the method ((Droplet 
DigitalTM PCR (DdPCRTM) Technology | LSR | Bio-Rad, n.d.)).   
High sensitivity is particularly important for wastewater surveillance of enveloped 
viruses, such as SARS-CoV-2. Enveloped viruses have shorter lifetimes in wastewater matrices 
than more common targets of WBE, resulting in minute concentrations of the virus in influent 
wastewaters. Such small quantities of virus make sensitivity crucial for identifying an optimal 
PCR-based method for wastewater surveillance of SARS-CoV-2. It is important to note that the 
method sensitivity evaluated in this study was based upon detection of SARS-CoV-2 in a 
specific wastewater matrix. No experiments included a true matrix control, as all wastewater had 
already been contaminated with SARS-CoV-2. As wastewater matrices differ across 
geographies, the analytical sensitivity for the detection of SARS-CoV-2 for RT-qPCR and RT-
ddPCR may differ when used in alternative contexts. Two studies comparing RT-qPCR and RT-
ddPCR performance, one for the detection of E. coli in bovine feces and the other for 
quantification of attenuated dengue virus in vaccines, found the methods to have comparable 
sensitivities. This indicates that the performance of the methods could vary among specific 
assays and extraction procedures (Abachin et al., 2018; Verhaegen et al., 2016). 
 Sensitivity of the RT-qPCR method is ultimately defined by the LOD and LOQ of the 
assay. These thresholds are important, as they help mitigate uncertainty in quantifying target 
concentrations. However, in the case of using RT-qPCR assays for the surveillance of single-
stranded nucleic acids in large volume environmental water samples, the LOD and LOQ 
threshold could potentially be limiting or discounting valuable data. With an average recovery 
efficiency for the BCoV processing control of 2.65%, it could be argued that detection of SARS-
CoV-2 at extremely low levels should be considered a valid result. Gonzalez et. al (2020) found 
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similarly low levels of recovery for bovine coronavirus, ranging from 2-7% throughout sample 
processing when using electronegative filtration for virus concentration. Other studies found a 
broad range of recoveries using alternative processing controls - murine hepatitis virus (65.7%), 
Dengue virus (8.1-52.7%), Mengovirus VMC0 (2.56-18.9%) and others, with similar sample 
processing methods (Ahmed, Bertsch, et al., 2020; Medema et al., 2020; Randazzo et al., 2020). 
The highly variable nature of the bovine coronavirus recoveries for RT-qPCR in this study (0.0-
58.9%) and across the literature may indicate that it is not the best choice for a processing 
control. Due to the unreliable nature of BCoV as a processing control, measured concentrations 
were not adjusted to account for loss during sample processing. Regardless of processing control 
reliability, if the samples detected and quantified at levels below the LOD for the RT-qPCR 
method were multiplied by the significant theoretical loss during sample processing, it would 
result in notable, high concentrations of the virus in the original sample. Using the LOD as a 
strict cutoff for defining non-detect samples would have excluded valuable data. Variation in 
viral recoveries must also be considered, but the theoretical significance it gives to samples 
quantified at values below the LOD still stands.  
 This significance does not discount the uncertainty inherent with values below an LOD 
and LOQ. A systematic approach is needed to mitigate that uncertainty, while still retaining the 
useful nature of the measured data. One option would be to classify the levels of detection based 
on the levels of measured certainty, as was done in this study. Values above the LOD/LOQ, have 
the highest level of certainty, and can therefore be reported as concentrations. Values below the 
LOQ have sufficient levels of certainty to indicate the presence of the virus as Positive but may 
not produce reliable concentrations. Values below the LOD have less certainty than the previous 
classifications, but still indicate the presence of virus in the sample. These values could be 
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reported as Positive (below LOD) in order to recognize that class of detection while 
acknowledging its corresponding level of uncertainty.  
 When including samples at all levels of detection, significant correlation increased 
between targets for both the OWASA and Pittsboro WWTPs (Table 4-3; Table 4-6). An increase 
in target correlation could indicate an increase in detection consistency. However, when 
measuring correlation of SARS-CoV-2 concentrations between the two methods, correlation and 
certainty increased when samples below the LOD of RT-qPCR were excluded and considered 
non-detects. Differences in detection rates between the two methods increased with the exclusion 
of samples measured at levels below the LOD (Table 4-12; Table 4-13). This indicates higher 
levels of certainty for SARS-CoV-2 concentrations quantified via RT-qPCR with the exclusion 
of values detected below the LOD but with the cost of a significant loss in detection rate. 
The lower levels of certainty and sensitivity present in the RT-qPCR method indicate the 
superiority of RT-ddPCR over RT-qPCR for detection and quantification of SARS-CoV-2 in 
wastewaters. However, the factors of cost and accessibility must be considered when comparing 
the two methods. Capital costs were approximately three times higher for RT-ddPCR, using the 
Bio-Rad QX200 Droplet Digital PCR System, than for RT-qPCR. Costs for the specific single-
plexed SARS-CoV-2 assay used in this study for RT-ddPCR was also more expensive than the 
single-plexed assay used for RT-qPCR. The turnaround time for the RT-qPCR assay used in this 
experiment was also approximately four times faster than that of the RT-ddPCR assay. Although 
these significant difference in financial cost exist, the public health cost must also be taken into 
account. It should be considered whether a more specific and sensitive method has the potential 
to be more effective in limiting the spread of SARS-CoV-2, thus saving lives. This potential cost 
of human lives is critical, however, it could also be argued that the current inaccessibility of 
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ddPCR systems, due to their novelty and cost, would result in the limitation of surveillance 
measures not their enhancement. qPCR systems are relatively common throughout municipal, 
academic, and state laboratories, and are generally more affordable. Standardizing RT-ddPCR as 
the method for wastewater surveillance of SARS-CoV-2 has the potential to pose significant and, 
at times unreasonable, financial burdens for laboratories across the state of North Carolina.  
As a result of these differences in accessibility, it is important to consider ways in which 
existing RT-qPCR resources could be best used for SARS-CoV-2 surveillance purposes. 
Including all classifications of data in analyses has the potential to yield a more informative RT-
qPCR dataset for specific-use scenarios. Due to the lack of measured inhibition from the 
wastewater matrix in RT-qPCR, samples would likely not have to be diluted. This is 
advantageous for the method, as dilution of samples could add to existing issues with detection 
sensitivity. Inhibition should, however, be evaluated for specific wastewater matrices, as the 
concentration of inhibitory compounds could vary across geographies and extraction methods. 
To mitigate increased uncertainty, RT-qPCR could be used solely for detection and not 
quantification of SARS-CoV-2.  Detections could be classified based upon their levels of relative 
certainty. Focusing only on detection-based purposes for RT-qPCR would remove the need for 
the high levels of certainty required for reporting concentrations. This also has the potential to 
improve the reliability of cross-lab comparisons of RT-qPCR results. Relying only on detection 
removes some of the uncertainty that comes with the broad range of RT-qPCR method 
variability across laboratories, and has the potential to improve and simplify comparison of 
surveillance data. If the situation required quantified concentrations, e.g. calculating case counts 
for wastewater-based epidemiology programs, quantification via RT-ddPCR would likely be the 
optimal method.  
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Variation in sampling methods between the two WWTPs was a limitation of this study. 
As sampling was completed by WWTP staff and not laboratory staff, control over sampling 
methods from the treatment process was limited. Observations of accelerated settling in the 
samples from the Pittsboro WWTP indicated that a coagulant was potentially added to the 
wastewater influent prior to sampling at the Pittsboro WWTP. As coagulants contain salts which 
act as inhibitors, this could be the cause of the inhibition present in the Pittsboro samples for RT-
ddPCR. Other limitations included limited volumes of common extractions for samples, which 
restricted the number of replicates and experiments for RT-qPCR. This ultimately reduced the 
statistical power of the RT-qPCR data set. Time to analysis between RNA extraction and SARS-
CoV-2 quantification also differed between the two methods, as RT-ddPCR experiments were 
run before RT-qPCR experiments. This is also a potential limitation of the direct method 
comparison in this study. 
The findings of this study comparing RT-qPCR and RT-ddPCR methods for the detection 
and quantification of SARS-CoV-2 in North Carolina wastewaters suggest a potential 
reevaluation of the use of LOD/LOQ thresholds in RT-qPCR that is not currently supported by 
the literature. Further studies are required to validate the limited use of data below the LOD/LOQ 
for the detection of SARS-CoV-2 in wastewaters and determine a systematic approach for data 











SARS-CoV-2 is detectable and quantifiable in NC wastewaters using various PCR-based 
methodologies. The specific strengths and weaknesses for each of the methods indicate that RT-
qPCR may be better suited for detection purposes and RT-ddPCR for quantification. Further 
comparison studies should be done to add to the characterization of these strengths and 
weaknesses for the purpose of SARS-CoV-2 surveillance. Both methods have the potential to 
serve as useful tools, individually and together, in the surveillance of SARS-CoV-2 in 

















 Standards Plate 1 - Ct values Plate 2 - Ct values Plate 3 - Ct values 
N1 
1 23.08 22.99 22.91 22.86 23.12 23.11 22.97 23.01 22.87 22.83 22.84 22.89 
2 26.39 26.27 26.32 26.28 26.61 26.53 26.67 26.55 26.49 26.42 26.52 26.37 
3 29.39 29.62 29.41 29.44 29.63 29.92 29.76 29.85 29.46 29.62 29.59 29.55 
4 33.44 33.33 32.87 33.92 33.58 34.15 33.61 33.39 33.56 33.21 34.11 34.05 
5 34.45 34.23 34.01 34.31 34.15 34.83 34.77 33.97 34.5 34.46 34.22 34.3 
6 36.44 35.05 36.59 35.72 35.9 35.06 37.95 35.3 35.21 35.28 35.63 36.25 
7 - - 36.29 37.2 36.73 35.35 - 35.57 35.59 36.7 36.59 35.3 
N2 
1 23.24 23.23 23.16 23.17 23.07 23.01 22.93 23.05 22.72 22.68 22.59 22.74 
2 26.76 26.76 26.9 26.79 26.52 26.6 26.65 26.53 26.43 26.22 26.5 26.36 
3 30.1 30.06 30.27 29.88 29.68 29.85 29.69 29.66 29.65 29.46 29.31 29.21 
4 33.62 34.41 33.33 33.47 33.42 33.46 33.37 33.18 33.34 33.25 33.05 33.26 
5 35 34.69 34.71 34.77 34.14 34.5 35.07 34.47 34.37 34.46 34.33 34.65 
6 36.58 35.08 35.94 36.07 35.42 35.84 36.35 36.15 36.25 35.46 35.77 34.81 
7 - 36.36 36.92 36.59 36.85 - 35.15 - 36.15 - 36.12 35.92 
Table A-1. Ct values used to calculate the LOD/LOQ for RT-qPCR. Standards were included if they produced 
a Ct value for 75% of replicates across plates. All standards included here were used for the calculation. Ct 
values are out of a 40 cycle program. 
 
 R2 % Efficiency Average Target AF Y-intercept Slope 
Plate 1 (N1) 0.9929 97.157 1.972 39.068 -3.392 
Plate 1 (N2) 0.9932 110.057 2.101 37.937 -3.102 
Plate 2 (N1) 0.9945 98.964 1.990 38.275 -3.347 
Plate 2 (N2) 0.9969 95.361 1.954 38.786 -3.438 
Plate 3 (N1) 0.9980 101.486 2.015 37.562 -3.287 
Plate 3 (N2) 0.9885 97.447 1.974 38.186 -3.385 
Plate 4 (N1) 0.9977 98.354 1.984 38.291 -3.362 
Plate 4 (N2) 0.9969 96.000 1.960 38.564 -3.422 
Plate 5 (N1) 0.9955 99.361 1.994 38.538 -3.337 
Plate 5 (N2) 0.9941 87.813 1.878 39.620 -3.653 
Plate 6 (BCoV) 0.9960 107.591 2.076 37.297 -3.153 
Plate 7 (BCoV) 0.9921 104.289 2.043 37.590 -3.223 
Plate 8 (SPUD) 0.9953 89.36 1.894 39.21 -3.606 









Average % Difference of Sample Cts 
from POS CTRL Ct 
EXT BL 10/27/20 -1.74% 
EXT BL 11/10/20 0.16% 
OWASA 10/13/20 -1.33% 
OWASA 10/6/20 -1.26% 
OWASA 11/10/20 2.22% 
OWASA 11/24/20 -1.76% 
OWASA 11/3/20 -1.11% 
OWASA 12/1/20 2.30% 
OWASA 12/15/20 0.27% 
OWASA 12/8/20 -2.07% 
OWASA 7/10/20 -1.28% 
OWASA 7/21/20 -1.83% 
OWASA 9/8/20 -100.00% 
PBS 10/13/20 -0.88% 
PITTSBORO 10/13/20 -1.14% 
PITTSBORO 11/10/20 -0.57% 
PITTSBORO 11/24/20 -0.82% 
PITTSBORO 11/3/20 -1.33% 
PITTSBORO 12/1/20 -1.44% 
PITTSBORO 12/15/20 -1.75% 
PITTSBORO 12/8/20 -2.22% 
PITTSBORO 7/21/20 -2.22% 
PITTSBORO 8/18/20 -1.75% 
PITTSBORO 9/15/20 -100.00% 
PITTSBORO 9/8/20 -100.00% 
Table A-3. Percent difference for Cts of spiked samples versus positive control samples for RT-qPCR 
inhibition experiment. The positive control Ct was set at 33.14. 
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7/10/20 OWASA N1 34.98 2465 2464 
7/10/20 OWASA N1 34.94 2533 2533 
7/14/20 OWASA N1 34.32 28948 28948 
7/21/20 OWASA N1 32.21 82889 82889 
7/21/20 OWASA N1 0 0 Negative 
7/28/20 OWASA N1 33.28 39170 39170.20 
7/28/20 OWASA N1 32.91 50761 50761 
8/6/20 OWASA N1 34.91 6252 Positive 
8/6/20 OWASA N1 34.32 9452 9452 
8/11/20 OWASA N1 35.55 3993 Positive 
8/11/20 OWASA N1 34.94 6122 Positive 
8/18/20 OWASA N1 0 0 Negative 
8/18/20 OWASA N1 0 0 Negative 
8/25/20 OWASA N1 0 0 Negative 
8/25/20 OWASA N1 0 0 Negative 
9/1/20 OWASA N1 0 0 Negative 
9/1/20 OWASA N1 0 0 Negative 
9/8/20 OWASA N1 0 0 Negative 
9/8/20 OWASA N1 0 0 Negative 
9/15/20 OWASA N1 0 0 Negative 
9/15/20 OWASA N1 0 0 Negative 
9/22/20 OWASA N1 38.46 685 Positive (below LOD) 
9/22/20 OWASA N1 37.24 1586 Positive (below LOD) 
9/29/20 OWASA N1 38.5 667 Positive (below LOD) 
9/29/20 OWASA N1 37.31 1511 Positive (below LOD) 
10/6/20 OWASA N1 38.22 808 Positive (below LOD) 
10/6/20 OWASA N1 36.01 3696 Positive 
10/13/20 OWASA N1 39.24 821 Positive (below LOD) 
10/13/20 OWASA N1 37.93 1998 Positive (below LOD) 
10/20/20 OWASA N1 36.69 4636 Positive 
10/20/20 OWASA N1 35.8 8483 8484 
10/27/20 OWASA N1 37.3 3064 Positive (below LOD) 
10/27/20 OWASA N1 0 0 Negative 
11/3/20 OWASA N1 37.5 2675 Positive 
11/3/20 OWASA N1 35.93 7766 7767 
11/10/20 OWASA N1 39.33 772 Positive (below LOD) 
11/10/20 OWASA N1 36.36 5800 Positive 
11/17/20 OWASA N1 36.82 4245 Positive 
11/17/20 OWASA N1 35.96 7610 7610 
11/24/20 OWASA N1 35.53 5056 Positive 
11/24/20 OWASA N1 35.29 5959 Positive 
12/1/20 OWASA N1 0 0 Negative 
12/1/20 OWASA N1 0 0 Negative 
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12/8/20 OWASA N1 34.5 20474 20474 
12/8/20 OWASA N1 34.45 21187 21187 
12/15/20 OWASA N1 35.16 13028 Positive 
12/15/20 OWASA N1 34.33 23001 23001 
7/10/20 PITTSBORO N1 36.8 703 Positive (below LOD) 
7/10/20 PITTSBORO N1 34.75 2887 2887 
7/14/20 PITTSBORO N1 36.89 4943 Positive (below LOD) 
7/14/20 PITTSBORO N1 0 0 Negative 
7/21/20 PITTSBORO N1 0 0 Negative 
7/21/20 PITTSBORO N1 0 0 Negative 
7/28/20 PITTSBORO N1 35.76 6893 Positive 
7/28/20 PITTSBORO N1 0 0 Negative 
8/6/20 PITTSBORO N1 36.26 2428 Positive (below LOD) 
8/6/20 PITTSBORO N1 0 0 Negative 
8/11/20 PITTSBORO N1 28.93 412465 412465 
8/11/20 PITTSBORO N1 28.54 542054 542054 
8/18/20 PITTSBORO N1 37.21 1248 Positive (below LOD) 
8/18/20 PITTSBORO N1 36.31 2344 Positive (below LOD) 
8/25/20 PITTSBORO N1 0 0 Negative 
8/25/20 PITTSBORO N1 0 0 Negative 
9/1/20 PITTSBORO N1 36.2 4774 Positive 
9/1/20 PITTSBORO N1 36.2 4774 Positive 
9/8/20 PITTSBORO N1 0 0 Negative 
9/8/20 PITTSBORO N1 0 0 Negative 
9/15/20 PITTSBORO N1 0 0 Negative 
9/15/20 PITTSBORO N1 0 0 Negative 
9/22/20 PITTSBORO N1 35.49 5285 Positive 
9/22/20 PITTSBORO N1 0 0 Negative 
9/29/20 PITTSBORO N1 0 0 Negative 
9/29/20 PITTSBORO N1 0 0 Negative 
10/6/20 PITTSBORO N1 0 0 Negative 
10/6/20 PITTSBORO N1 0 0 Negative 
10/13/20 PITTSBORO N1 39.9 524 Positive (below LOD) 
10/13/20 PITTSBORO N1 0 0 Negative 
10/20/20 PITTSBORO N1 36.84 4187 Positive 
10/20/20 PITTSBORO N1 0 0 Negative 
10/27/20 PITTSBORO N1 39.58 651 Positive (below LOD) 
10/27/20 PITTSBORO N1 0 0 Negative 
11/3/20 PITTSBORO N1 38.95 999 Positive (below LOD) 
11/3/20 PITTSBORO N1 0 0 Negative 
11/10/20 PITTSBORO N1 0 0 Negative 
11/10/20 PITTSBORO N1 0 0 Negative 
11/17/20 PITTSBORO N1 0 0 Negative 
11/17/20 PITTSBORO N1 0 0 Negative 
11/24/20 PITTSBORO N1 37.01 1834 Positive (below LOD) 
11/24/20 PITTSBORO N1 36.13 3352 Positive 
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12/1/20 PITTSBORO N1 35.83 4116 Positive 
12/1/20 PITTSBORO N1 0 0 Negative 
12/8/20 PITTSBORO N1 36.98 3746 Positive (below LOD) 
12/8/20 PITTSBORO N1 36.39 5611 Positive 
12/15/20 PITTSBORO N1 36.81 2104 Positive (below LOD) 
12/15/20 PITTSBORO N1 36.49 2620 Positive 
7/10/20 OWASA N2 35.08 3766 3766 
7/10/20 OWASA N2 35.01 3951 3951 
7/14/20 OWASA N2 35.06 16104 Positive 
7/21/20 OWASA N2 33.02 24594 24594 
7/21/20 OWASA N2 32.24 41810 41810 
7/28/20 OWASA N2 34.16 11324 11324 
7/28/20 OWASA N2 33.74 15070 15070 
8/6/20 OWASA N2 36.33 2588 Positive (below LOD) 
8/6/20 OWASA N2 34.99 6439 Positive 
8/11/20 OWASA N2 0 0 Negative 
8/11/20 OWASA N2 0 0 Negative 
8/18/20 OWASA N2 0 0 Negative 
8/18/20 OWASA N2 0 0 Negative 
8/25/20 OWASA N2 0 0 Negative 
8/25/20 OWASA N2 0 0 Negative 
9/1/20 OWASA N2 38.83 0 Positive (below LOD) 
9/1/20 OWASA N2 0 0 Negative 
9/8/20 OWASA N2 0 0 Negative 
9/8/20 OWASA N2 0 0 Negative 
9/15/20 OWASA N2 38.11 1216 Positive (below LOD) 
9/15/20 OWASA N2 0 0 Negative 
9/22/20 OWASA N2 0 0 Negative 
9/22/20 OWASA N2 0 0 Negative 
9/29/20 OWASA N2 0 0 Negative 
9/29/20 OWASA N2 0 0 Negative 
10/6/20 OWASA N2 0 0 Negative 
10/6/20 OWASA N2 0 0 Negative 
10/13/20 OWASA N2 37.15 1037 Positive (below LOD) 
10/13/20 OWASA N2 0 0 Negative 
10/20/20 OWASA N2 35.84 2743 Positive 
10/20/20 OWASA N2 35.76 2911 Positive 
10/27/20 OWASA N2 35.72 2999 Positive 
10/27/20 OWASA N2 35.48 3583 Positive 
11/3/20 OWASA N2 35.98 2472 Positive 
11/3/20 OWASA N2 0 0 Negative 
11/10/20 OWASA N2 38.04 536 Positive (below LOD) 
11/10/20 OWASA N2 36.51 1668 Positive (below LOD) 
11/17/20 OWASA N2 36.67 1481 Positive (below LOD) 
11/17/20 OWASA N2 36.49 1693 Positive (below LOD) 
11/24/20 OWASA N2 38.08 1087 Positive (below LOD) 
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11/24/20 OWASA N2 37.54 1563 Positive (below LOD) 
12/1/20 OWASA N2 0 0 Negative 
12/1/20 OWASA N2 0 0 Negative 
12/8/20 OWASA N2 37.69 1413 Positive (below LOD) 
12/8/20 OWASA N2 35.69 5427 Positive 
12/15/20 OWASA N2 0 0 Negative 
12/15/20 OWASA N2 0 0 Negative 
7/10/20 PITTSBORO N2 36.27 1666 Positive 
7/10/20 PITTSBORO N2 35.59 2655 Positive 
7/14/20 PITTSBORO N2 0 0 Negative 
7/14/20 PITTSBORO N2 0 0 Negative 
7/21/20 PITTSBORO N2 36.23 2770 Positive 
7/21/20 PITTSBORO N2 35.59 4281 Positive 
7/28/20 PITTSBORO N2 37.91 883 Positive (below LOD) 
7/28/20 PITTSBORO N2 0 0 Negative 
8/6/20 PITTSBORO N2 0 0 Negative 
8/6/20 PITTSBORO N2 0 0 Negative 
8/11/20 PITTSBORO N2 29.7 235354 235354 
8/11/20 PITTSBORO N2 29.41 286683 286683 
8/18/20 PITTSBORO N2 35.19 5620 Positive 
8/18/20 PITTSBORO N2 34.64 8170 8170 
8/25/20 PITTSBORO N2 0 0 Negative 
8/25/20 PITTSBORO N2 0 0 Negative 
9/1/20 PITTSBORO N2 38.89 1780 Positive (below LOD) 
9/8/20 PITTSBORO N2 37.22 2207 Positive (below LOD) 
9/8/20 PITTSBORO N2 0 0 Negative 
9/15/20 PITTSBORO N2 37.02 2523 Positive (below LOD) 
9/15/20 PITTSBORO N2 0 0 Negative 
9/22/20 PITTSBORO N2 37.3 2091 Positive (below LOD) 
9/22/20 PITTSBORO N2 0 0 Negative 
9/29/20 PITTSBORO N2 36.52 3526 Positive 
9/29/20 PITTSBORO N2 0 0 Negative 
10/6/20 PITTSBORO N2 0 0 Negative 
10/6/20 PITTSBORO N2 0 0 Negative 
10/13/20 PITTSBORO N2 0 0 Negative 
10/13/20 PITTSBORO N2 0 0 Negative 
10/20/20 PITTSBORO N2 36.78 1365 Positive (below LOD) 
10/20/20 PITTSBORO N2 36.52 1656 Positive (below LOD) 
10/27/20 PITTSBORO N2 37.42 849 Positive (below LOD) 
10/27/20 PITTSBORO N2 0 0 Negative 
11/3/20 PITTSBORO N2 37.73 675 Positive (below LOD) 
11/3/20 PITTSBORO N2 37.25 963 Positive (below LOD) 
11/10/20 PITTSBORO N2 0 0 Negative 
11/10/20 PITTSBORO N2 0 0 Negative 
11/17/20 PITTSBORO N2 0 0 Negative 











7/10/20 OWASA N1 28846 
7/10/20 OWASA N1 19374 
7/14/20 OWASA N1 17416 
7/14/20 OWASA N1 22386 
7/21/20 OWASA N1 67630 
7/21/20 OWASA N1 69901 
7/28/20 OWASA N1 Negative 
7/28/20 OWASA N1 24790 
8/6/20 OWASA N1 6200 
8/6/20 OWASA N1 17700 
8/11/20 OWASA N1 15870 
8/11/20 OWASA N1 19576 
8/18/20 OWASA N1 138075 
8/18/20 OWASA N1 142690 
8/25/20 OWASA N1 77822 
8/25/20 OWASA N1 71310 
9/1/20 OWASA N1 36952 
9/1/20 OWASA N1 11314 
9/8/20 OWASA N1 12617 
9/8/20 OWASA N1 10579 
9/15/20 OWASA N1 3428 
9/22/20 OWASA N1 12696 
9/22/20 OWASA N1 12848 
9/29/20 OWASA N1 21388 
9/29/20 OWASA N1 19595 
10/6/20 OWASA N1 6479 
10/6/20 OWASA N1 6066 
11/24/20 PITTSBORO N2 37.39 1729 Positive (below LOD) 
11/24/20 PITTSBORO N2 37.33 1800 Positive (below LOD) 
12/1/20 PITTSBORO N2 38.24 976 Positive (below LOD) 
12/1/20 PITTSBORO N2 37.53 1573 Positive (below LOD) 
12/8/20 PITTSBORO N2 35.91 4680 Positive 
12/8/20 PITTSBORO N2 0 0 Negative 
12/15/20 PITTSBORO N2 39.5 418 Positive (below LOD) 
12/15/20 PITTSBORO N2 0 0 Negative 
Table A-4. All RT-qPCR replicates across both targets and WWTPs. Replicate classification is included. 
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10/13/20 OWASA N1 5272 
10/13/20 OWASA N1 3057 
10/20/20 OWASA N1 10175 
10/20/20 OWASA N1 15937 
10/27/20 OWASA N1 Negative 
10/27/20 OWASA N1 Negative 
11/3/20 OWASA N1 6296 
11/3/20 OWASA N1 8273 
11/10/20 OWASA N1 Negative 
11/10/20 OWASA N1 Negative 
11/17/20 OWASA N1 13437 
11/17/20 OWASA N1 17133 
11/24/20 OWASA N1 14374 
11/24/20 OWASA N1 18899 
12/1/20 OWASA N1 3939 
12/1/20 OWASA N1 Negative 
12/8/20 OWASA N1 4767 
12/8/20 OWASA N1 13575 
12/15/20 OWASA N1 45897 
12/15/20 OWASA N1 45076 
7/10/20 PITTSBORO N1 24197 
7/10/20 PITTSBORO N1 27966 
7/14/20 PITTSBORO N1 Negative 
7/14/20 PITTSBORO N1 Negative 
7/21/20 PITTSBORO N1 Negative 
7/21/20 PITTSBORO N1 12369 
7/28/20 PITTSBORO N1 Negative 
7/28/20 PITTSBORO N1 Negative 
8/6/20 PITTSBORO N1 Negative 
8/6/20 PITTSBORO N1 Negative 
8/11/20 PITTSBORO N1 221289 
8/11/20 PITTSBORO N1 193390 
8/18/20 PITTSBORO N1 7302 
8/18/20 PITTSBORO N1 Negative 
8/25/20 PITTSBORO N1 7854 
8/25/20 PITTSBORO N1 8741 
9/1/20 PITTSBORO N1 Negative 
9/1/20 PITTSBORO N1 43592 
9/8/20 PITTSBORO N1 40425 
9/8/20 PITTSBORO N1 33359 
9/15/20 PITTSBORO N1 3428 
9/22/20 PITTSBORO N1 15685 
9/22/20 PITTSBORO N1 7089 
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9/29/20 PITTSBORO N1 21510 
9/29/20 PITTSBORO N1 12302 
10/6/20 PITTSBORO N1 Negative 
10/6/20 PITTSBORO N1 Negative 
10/13/20 PITTSBORO N1 6042 
10/13/20 PITTSBORO N1 7682 
10/20/20 PITTSBORO N1 4498 
10/20/20 PITTSBORO N1 Negative 
10/27/20 PITTSBORO N1 Negative 
10/27/20 PITTSBORO N1 3423 
11/3/20 PITTSBORO N1 4093 
11/3/20 PITTSBORO N1 Negative 
11/10/20 PITTSBORO N1 5347 
11/10/20 PITTSBORO N1 Negative 
11/17/20 PITTSBORO N1 27060 
11/17/20 PITTSBORO N1 15056 
11/24/20 PITTSBORO N1 8753 
11/24/20 PITTSBORO N1 Negative 
12/1/20 PITTSBORO N1 Negative 
12/1/20 PITTSBORO N1 Negative 
12/8/20 PITTSBORO N1 6026 
12/8/20 PITTSBORO N1 10325 
12/15/20 PITTSBORO N1 7809 
12/15/20 PITTSBORO N2 4672 
7/10/20 OWASA N2 22082 
7/10/20 OWASA N2 17132 
7/14/20 OWASA N2 13727 
7/14/20 OWASA N2 Negative 
7/21/20 OWASA N2 64701 
7/21/20 OWASA N2 40366 
7/28/20 OWASA N2 30443 
7/28/20 OWASA N2 29594 
8/6/20 OWASA N2 Negative 
8/6/20 OWASA N2 Negative 
8/11/20 OWASA N2 16088 
8/11/20 OWASA N2 30322 
8/18/20 OWASA N2 51288 
8/18/20 OWASA N2 62169 
8/25/20 OWASA N2 50516 
8/25/20 OWASA N2 68429 
9/1/20 OWASA N2 16326 
9/1/20 OWASA N2 7860 
9/8/20 OWASA N2 Negative 
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9/8/20 OWASA N2 Negative 
9/15/20 OWASA N2 Negative 
9/22/20 OWASA N2 17807 
9/22/20 OWASA N2 15235 
9/29/20 OWASA N2 10078 
9/29/20 OWASA N2 9905 
10/6/20 OWASA N2 13005 
10/6/20 OWASA N2 10312 
10/13/20 OWASA N2 11246 
10/13/20 OWASA N2 Negative 
10/20/20 OWASA N2 10357 
10/20/20 OWASA N2 11478 
10/27/20 OWASA N2 Negative 
10/27/20 OWASA N2 3684 
11/3/20 OWASA N2 3377 
11/3/20 OWASA N2 7667 
11/10/20 OWASA N2 Negative 
11/10/20 OWASA N2 4246 
11/17/20 OWASA N2 11779 
11/17/20 OWASA N2 26349 
11/24/20 OWASA N2 9899 
11/24/20 OWASA N2 12583 
12/1/20 OWASA N2 Negative 
12/1/20 OWASA N2 Negative 
12/8/20 OWASA N2 9665 
12/8/20 OWASA N2 5892 
12/15/20 OWASA N2 55297 
12/15/20 OWASA N2 51303 
7/10/20 PITTSBORO N2 14790 
7/10/20 PITTSBORO N2 17586 
7/14/20 PITTSBORO N2 Negative 
7/14/20 PITTSBORO N2 Negative 
7/21/20 PITTSBORO N2 Negative 
7/21/20 PITTSBORO N2 Negative 
7/28/20 PITTSBORO N2 Negative 
7/28/20 PITTSBORO N2 Negative 
8/6/20 PITTSBORO N2 Negative 
8/6/20 PITTSBORO N2 Negative 
8/11/20 PITTSBORO N2 280414 
8/11/20 PITTSBORO N2 279138 
8/18/20 PITTSBORO N2 16431 
8/18/20 PITTSBORO N2 17930 
8/25/20 PITTSBORO N2 3684 
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8/25/20 PITTSBORO N2 3903 
9/1/20 PITTSBORO N2 Negative 
9/1/20 PITTSBORO N2 Negative 
9/8/20 PITTSBORO N2 28414 
9/8/20 PITTSBORO N2 33592 
9/15/20 PITTSBORO N2 Negative 
9/22/20 PITTSBORO N2 29996 
9/22/20 PITTSBORO N2 26050 
9/29/20 PITTSBORO N2 11279 
9/29/20 PITTSBORO N2 15155 
10/6/20 PITTSBORO N2 Negative 
10/6/20 PITTSBORO N2 Negative 
10/13/20 PITTSBORO N2 4217 
10/13/20 PITTSBORO N2 5141 
10/20/20 PITTSBORO N2 Negative 
10/20/20 PITTSBORO N2 6615 
10/27/20 PITTSBORO N2 4434 
10/27/20 PITTSBORO N2 8776 
11/3/20 PITTSBORO N2 Negative 
11/3/20 PITTSBORO N2 Negative 
11/10/20 PITTSBORO N2 Negative 
11/10/20 PITTSBORO N2 7040 
11/17/20 PITTSBORO N2 10069 
11/17/20 PITTSBORO N2 17987 
11/24/20 PITTSBORO N2 Negative 
11/24/20 PITTSBORO N2 Negative 
12/1/20 PITTSBORO N2 4698 
12/1/20 PITTSBORO N2 5798 
12/8/20 PITTSBORO N2 16344 
12/8/20 PITTSBORO N2 8331 
12/15/20 PITTSBORO N2 11692 
12/15/20 PITTSBORO N2 12533 
Table A-5. All RT-ddPCR replicates across both targets and WWTPs. Replicate classification is included 
(LaMontagne et al., 2021). 
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